Skip to main content
Premium Trial:

Request an Annual Quote

Rescentris Secures Series A Funding

NEW YORK, May 4 (GenomeWeb News) - Rescentris, a provider of electronic laboratory notebook software, said today that it has completed its Series A financing.

 

The company did not disclose the amount of funding, but said that it will be used to expand its sales and marketing programs and further development of its flagship product, the Collaborative Electronic Research Framework (CERF).

 

Initial development of CERF was funded in part by a grant from the State of Ohio's Third Frontier Project, Rescentris said.

 

The product was developed in collaboration with OhioStateUniversity's BioMedical Informatics department.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.